Related Experiment Videos
Tetracycline-resistant Chlamydia trachomatis in Toulouse, France
J C Lefevre1, J P Lepargneur, D Guion
1Laboratoire de Prévention des Maladies Transmissibles Sexuellement, Faculté de Médecine, Hôpital Purpan, TOULOUSE, France.
Pathologie-Biologie
|May 1, 1997
Summary
The first tetracycline-resistant Chlamydia trachomatis strain was identified in Toulouse, France. This discovery may impact the management of chlamydial infections, necessitating alternative treatment strategies.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Chlamydia trachomatis is a common bacterial STD.
- Tetracycline is a standard treatment for chlamydial infections.
- Emergence of antimicrobial resistance is a growing public health concern.
Purpose of the Study:
- To report the first isolation of a tetracycline-resistant Chlamydia trachomatis strain.
- To characterize the resistance profile of the identified strain.
- To discuss the implications for chlamydial infection management.
Main Methods:
- Culture of a post-treatment endocervical specimen.
- Determination of minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) for tetracycline.
- Comparison with historical C. trachomatis isolates.
Main Results:
- A tetracycline-resistant C. trachomatis strain was isolated from a patient in Toulouse, France.
- The patient isolate exhibited high MIC (> 64 µg/ml) and MBC values for tetracycline.
- Previous isolates from Toulouse showed high susceptibility to tetracycline (MIC ≤ 0.25 µg/ml).
Conclusions:
- The isolation of tetracycline-resistant C. trachomatis represents a significant clinical finding.
- This resistance may necessitate changes in treatment guidelines for chlamydial infections.
- Further surveillance and research are needed to monitor and address antimicrobial resistance in C. trachomatis.